Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects

NCT00964665 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
141
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals

Collaborators